157 related articles for article (PubMed ID: 1558116)
1. Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits.
Assil KK; Zarnegar SR; Fouraker BD; Schanzlin DJ
Am J Ophthalmol; 1992 Apr; 113(4):418-23. PubMed ID: 1558116
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
Silbiger J; Stern GA
Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
[TBL] [Abstract][Full Text] [Related]
3. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
Assil KK; Frucht-Perry J; Ziegler E; Schanzlin DJ; Schneiderman T; Weinreb RN
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3216-20. PubMed ID: 1748553
[TBL] [Abstract][Full Text] [Related]
4. Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis.
Frucht-Perry J; Assil KK; Ziegler E; Douglas H; Brown SI; Schanzlin DJ; Weinreb RN
Cornea; 1992 Sep; 11(5):393-7. PubMed ID: 1424666
[TBL] [Abstract][Full Text] [Related]
5. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.
Hobden JA; Reidy JJ; O'Callaghan RJ; Hill JM; Insler MS; Rootman DS
Arch Ophthalmol; 1988 Nov; 106(11):1605-7. PubMed ID: 3142450
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
Callegan MC; Engel LS; Clinch TE; Hill JM; Kaufman HE; O'Callaghan RJ
Curr Eye Res; 1994 Dec; 13(12):875-8. PubMed ID: 7720394
[TBL] [Abstract][Full Text] [Related]
8. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
9. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Lauffenburger MD; Cohen KL
Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
[TBL] [Abstract][Full Text] [Related]
10. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
Rootman DS; Hobden JA; Jantzen JA; Gonzalez JR; O'Callaghan RJ; Hill JM
Arch Ophthalmol; 1988 Feb; 106(2):262-5. PubMed ID: 3124801
[TBL] [Abstract][Full Text] [Related]
11. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Hobden JA; Reidy JJ; O'Callaghan RJ; Insler MS; Hill JM
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2241-3. PubMed ID: 2173684
[TBL] [Abstract][Full Text] [Related]
12. Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
Hobden JA; O'Callaghan RJ; Hill JM; Reidy JJ; Rootman DS; Thompson HW
Curr Eye Res; 1989 Nov; 8(11):1163-9. PubMed ID: 2515036
[TBL] [Abstract][Full Text] [Related]
13. Intracanalicular collagen implants enhance topical antibiotic bioavailability.
Gilbert ML; Wilhelmus KR; Osato MS
Cornea; 1986; 5(3):167-71. PubMed ID: 2980835
[No Abstract] [Full Text] [Related]
14. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
Reidy JJ; Hobden JA; Hill JM; Forman K; O'Callaghan RJ
Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
[TBL] [Abstract][Full Text] [Related]
17. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
Gritz DC; McDonnell PJ; Lee TY; Tang-Liu D; Hubbard BB; Gwon A
Cornea; 1992 Mar; 11(2):143-7. PubMed ID: 1582217
[TBL] [Abstract][Full Text] [Related]
18. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
19. Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits.
Er H; Turkoz Y; Ozerol IH; Uzmez E
Eur J Ophthalmol; 1998; 8(3):137-41. PubMed ID: 9793765
[TBL] [Abstract][Full Text] [Related]
20. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
Pleyer U; Legmann A; Mondino BJ; Lee DA
Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
